O

Option Care Health

Largest independent home infusion therapy provider

Nursing Supervisor

Full-Time
$80.6k - $134.3k+ 401(k) company match
Junior, Mid
Bachelor's
Melbourne, FL, USA
In PersonWillingness to travel at least 50% of the time for business, within and outside the state.
Medical, Clinical & VeterinaryNursing & Frontline Patient Care

About the job

Requirements
  • Registered Nurse with a license in the current state of practice and either 1 year of nursing supervisory or charge experience, or at least 3 years of relevant nursing experience with demonstrated progression.
  • Required certification in cardiopulmonary resuscitation (CPR), with an in-person class required by company policy.
  • Membership in a state or national professional organization.
  • Reliable transportation enabling home visits; if using a personal vehicle, a valid driver's license and proof of insurance are required.
  • Experience applying local, state, federal, accrediting body, and Occupational Safety and Health Administration rules and regulations.
  • Experience providing customer service to internal and external customers, meeting service quality standards, and evaluating customer satisfaction.
  • Experience in indirect team management, including assisting with team member development, training, and assignment of work or projects.
  • Time-management experience prioritizing, organizing, and tracking details while meeting deadlines for multiple projects with varying completion dates.
  • Basic proficiency with Microsoft Word, including editing and formatting documents, using find and replace, spell check and track changes, and printing.
  • Basic proficiency with Microsoft Excel, including workbook and cell formatting, copying, pasting, saving, sorting, chart and worksheet operations, page setup, spell check, and printing.
  • Basic proficiency with Microsoft PowerPoint, including creating and managing slides, editing text, inserting tables or notes, moving objects, printing outlines, and running slide shows.
  • Ability to accomplish goals with little or no supervision, complete objectives independently, and determine when issues require escalation.
  • Physical ability to perform CPR and related emergency response duties and maintain that ability; periodic reevaluation may be required.
  • Successful completion of a company background check, drug screen, and Florida Care Provider Background Screening Clearinghouse screening and enrollment.
Responsibilities
  • Provide direct and indirect patient care under a physician’s plan of care and in accordance with company policies, state professional standards, and regulatory requirements.
  • Provide and oversee patient assessments, care planning, patient and caregiver education, evaluation of progress toward goals, and recommendations for changes to the plan of care.
  • Maintain clinical competency by providing direct patient care 20–40% of the time.
  • Manage home infusion patient care, including patient management, the nursing process, and applicable federal, state, and local home health agency requirements.
  • Apply documentation and billing requirements for home health and infusion care goods and services.
  • Determine patients’ suitability for home care.
  • Supervise, monitor, and evaluate the quality and effectiveness of patient care, including in-home evaluations of field staff when appropriate.
  • Review and monitor nursing care plans and direct staff to modify plans as needed.
  • Act as administrator and/or director of nursing for Medicare-certified home health agencies in the absence of the director or nursing manager.
  • Manage daily operations and communications, maintain office compliance with regulatory and accreditation entities, meet reporting requirements, monitor policy and procedure compliance, and evaluate medical supply usage.
  • Participate in assessing, managing, and reporting nursing operational and financial data to nursing and operations leadership, and support development and implementation of each patient’s plan of care.
  • Develop, implement, evaluate, and participate in office-specific continuing education and orientation programs.
  • Assist nursing and operations leaders in recruiting, developing, and monitoring new staff.
  • Coordinate and participate in on-call responsibilities, and maintain confidentiality of patient and proprietary information.
  • Participate in or direct the professional advisory committee, infection prevention and process improvement teams, including conducting chart audits.
  • Identify improvement opportunities and communicate them to nursing and operations leadership.
  • Explain available services and provide ongoing support to sales professionals.
  • Travel at least 50% of the time for business within and outside the state.
Desired Qualifications
  • Bachelor of Science in Nursing (BSN).
  • Certified Registered Nurse Infusion (CRNI) or another professional certification.
  • At least 1 year of supervisory experience in a hospital or home health care setting.
  • At least 1 year of experience in indirect team management, including assisting with team member development, training, and assignment of work or projects.

About the company

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Bannockburn, Illinois

Founded

1979

Get referred to Option Care Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 29, 2026 Q2 revenue reached $1.44 billion, while acute therapy and IG Neuro strengthened.
  • Management stabilized CID patient census in Q2 2026 and kept full-year revenue guidance unchanged.
  • The company repurchased $150 million in Q2 2026, signaling confidence and shareholder-return capacity.

What critics are saying

  • August 2026 guidance still bakes in a 600-basis-point CID revenue headwind and $55 million gross profit hit.
  • July 29, 2026 Q2 buyback of $150 million masks weak top-line momentum and analyst skepticism.
  • Biosimilar erosion and payer reverification pressure can permanently shrink chronic volumes if retention stays broken.

What makes Option Care Health unique

  • Option Care Health leads U.S. independent home and alternate-site infusion, with nationwide clinician density.
  • Its payer, biopharma, and prescriber relationships create switching costs across chronic and acute therapies.
  • August 27, 2026 guidance shows durable cash generation, with at least $320 million operating cash flow.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Time Off
  • Bonding Time Off
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Health Savings Account/Flexible Spending Account
  • Flexible Spending Accounts
  • Tuition Reimbursement
  • Family Support
  • Mental Health Support

Company News

AD HOC NEWS
Oct 15th, 2026
McKesson commits $1.4B for 49% stake in Option Care at $5.8B valuation

McKesson will invest $1.4 billion for a 49% minority stake in Option Care Health, under an agreement announced on October 6, 2026. The deal values Option Care at an enterprise value of $5.8 billion. Clayton, Dubilier & Rice will hold about 51%. Option Care will stay separately managed, while McKesson keeps a framework to acquire the remaining interest later, subject to conditions and regulatory approvals. In its first fiscal 2027 quarter, McKesson reported revenue of $105.38 billion, up 7.7% year on year, and adjusted earnings per share of $9.93. It will report second-quarter results on November 4, 2026.

Yahoo Finance
Oct 6th, 2026
McKesson and Clayton Dubilier & Rice near $5B deal to acquire Option Care Health

Option Care Health shares jumped 33.2% in pre-market trading after the Financial Times reported McKesson and Clayton Dubilier & Rice are nearing a transaction valued at over $5 billion to acquire the alternate site health provider. According to the report, the deal would involve the two firms partnering to buy the infusion services provider, which they view as undervalued. Large-scale buyout discussions typically drive market optimism as investors anticipate acquisition premiums. The move is significant for Option Care Health, whose shares have experienced 13 movements greater than 5% over the past year. At $31.03 per share, the stock is trading 15.2% below its 52-week high but remains down 3.8% year-to-date.

Central Charts
Oct 6th, 2026
CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health

CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today that they have

Yahoo Finance
Jul 29th, 2026
Option Care Health Q2 beats expectations with $1.4B revenue, narrows full-year guidance

Option Care Health reported second-quarter 2026 results that exceeded expectations. Revenue rose 7% sequentially to $1.4 billion, whilst adjusted EBITDA increased 12% to $117.5 million and adjusted EPS reached $0.45. Operating cash flow totalled $184 million. Acute therapies posted high-single-digit organic growth, while chronic revenue improved sequentially as the CID portfolio began to stabilise. However, CID-related pressure is expected to reduce 2026 revenue by roughly 600 basis points and gross profit by $55 million. The home and alternate-site infusion provider maintained its full-year revenue guidance at $5.675 billion to $5.775 billion. Adjusted EBITDA guidance was narrowed to $480 million to $495 million, and adjusted EPS guidance to $1.85 to $1.92. The company repurchased $150 million of shares, nearly 5% of shares outstanding.

Yahoo Finance
Jul 29th, 2026
Option Care Health reports $1.44B Q2 revenue, up 1.9%, and raises $150M share buyback

Option Care Health, the largest independent provider of home and alternate site infusion services in the US, reported second quarter 2026 results. Net revenue reached $1.44 billion, up 1.9% year-over-year. The company posted net income of $53.9 million, up 6.7%, with diluted earnings per share of $0.35, up 12.9%. Adjusted EBITDA grew 3.0% to $117.5 million. The company repurchased $150 million of outstanding shares during the quarter. For full year 2026, Option Care Health expects net revenue between $5.68 billion and $5.78 billion, with adjusted diluted earnings per share of $1.85 to $1.92. The company forecasts adjusted EBITDA of $480 million to $495 million and operating cash flow of at least $320 million.